StockpollyBeta
Get App
Delisting riskPopularity #4,870
NXL · NASDAQ · Medical - Devices

Nexalin Technology (NXL)

Non-invasive brain-stimulation systems for clinical and physician-supervised home care.

$4.68
vs last close+0.05 (+0.98%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000010
Gross profit000000000000
221133222322
Research & development200001000001
201122212211
Selling & marketing2011−11112210
General & administrative000030000001
Other expenses−210000000001
Operating income−2−2−1−1−3−3−2−2−2−2−2−2
010000000000
Interest income000000000000
Interest expense000000000000
Other non-operating income0−10000000000
Income before tax−2−1−1−1−2−3−2−2−2−2−2−2
Net income from continuing operations−2−1−1−1−2−3−2−2−2−2−2−2
Net income−2−1−1−1−2−3−2−2−2−2−2−2
EPS, basic−$0.31−$3.00−$4.20−$5.10−$6.90−$8.70−$4.50−$3.00−$3.90−$3.90−$3.30−$3.30
EPS, diluted−$0.31−$3.00−$4.20−$5.10−$6.90−$8.70−$4.50−$3.00−$3.90−$3.90−$3.30−$3.30
Weighted average shares, basic700000011111
Weighted average shares, diluted700000011111
EBITDA−2−1−1−1−2−3−2−2−2−2−2−2
Depreciation & amortization000000000000
EBIT−2−1−1−1−2−3−2−2−2−2−2−2